RISE is a large, regionally-representative cohort study of US women aged 18 and older. Potential participants were selected randomly from a marketing database and were required to reside in one of 50 counties including and surrounding the nine PLUS recruitment sites. Invitations to complete two 30-minute baseline surveys (on a web portal or on paper) were mailed to potential participants between May 2022 and May 2023. The baseline surveys included the BHS/BFI, the 10-item Symptoms of Lower Urinary Tract Dysfunction Symptom Index (LURN SI-10) [3], and multiple additional study items. The BHS/BFI is a comprehensive instrument that assesses bladder well-being across 10 domains (global, holding, perceived efficacy, social-occupation, physical activity, intimacy, travel, emotion, perception, and freedom), and bladder function across six functions (biosis/urinary tract infection, frequency, sensation, continence, comfort, and emptying). Scores for the BHS and BFI range from 0 (poor well-being/function) to 100 (optimal well-being/function). BHS scores are additionally adjusted for adaptive/coping behaviors (e.g., wearing/carrying pads, staying close to a toilet), as these behaviors may potentially minimize the perceived impact of LUTS on well-being [2]. The LURN SI-10 assesses the frequency of 10 lower urinary tract signs or symptoms, including daytime urinary frequency, nighttime urinary frequency, urgency, urgency and stress urinary incontinence, hesitancy, slow urinary stream, terminal dribbling, and pain or discomfort with bladder filling. We used this index to identify participants without self-reported LUTS, which we defined as an average daytime voiding frequency of <8 times/day, nighttime voiding frequency of <2 times/night, and a report of “never” in the past seven days for all other symptoms. We calculated medians and interquartile ranges (IQRs) for each BHS (with and without adaptive behavior adjustment) and BFI in the full study population and the subset of women without self-reported LUTS.